Tag: cx 2023
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82....
“EndoAVF 2.0” projects evaluated in CX debate
The advent of endovascular arteriovenous fistula (endoAVF) creation with the development of the Ellipsys (Medtronic) and WavelinQ (BD) systems marks a “major innovation in...
Next-generation endoAVF technologies promise to expand candidate patient population
Endovascular arteriovenous fistula (endoAVF) creation marks a “major innovation in dialysis access”, while a “mounting evidence base” demonstrates their high functional patency rates. Now,...
First-in-human aXess graft trial shows high patency and low reintervention rates
“Absolutely novel and exciting”—that is how Frans Moll (University Medical Center Utrecht, Utrecht, The Netherlands) has described the aXess haemodialysis vascular graft as he...
How effective is cost effectiveness for dialysis patients?
Attendees at the 2023 Charing Cross (CX) Symposium (25–27 April, London, UK) renal interventions session were treated to two presentations exploring the issue of...
CX 2023: IN.PACT AV three-year subanalysis trial data show “durable” long-term...
The vascular access masterclass session on Tuesday saw a first-to-podium presentation by Andrew Holden (Auckland City Hospital, Auckland, New Zealand) in which he presented...
CX 2023: Peritoneal dialysis underutilised “across the world” despite advantages
Peritoneal dialysis (PD) has a number of advantages over haemodialysis—yet with a few exceptions, it is underutilised in most countries. So went the argument...